Jonathan Yeh
Founder at Saisei Ventures LLC
Profile
Jonathan is managing partner at Saisei Ventures and serves as a director of the general partner, Saisei Capital Ltd.
Jonathan’s experience encompasses venture company creation and investment, cell and gene therapy operations, and portfolio management.
He has held various investment roles at Healios K.K.
and CCRM, and he previously served as Executive Director of the Genome Canada Large Scale Applied Research Project, The Leucegene Project, where he led implementation and commercialization efforts of novel diagnostics for acute leukemia.
Jonathan was a CIHR Post-doctoral Fellow at the Institute for Research in Immunology and Cancer, Université de Montréal, received his MBA from the John Molson School of Business at Concordia University and his PhD from McGill University.
Additionally, he co-founded Ryne Biotechnology, an iPSC-focused neurodegeneration company in San Diego and serves in various advisory roles for the International Society of Cell and Gene Therapy (ISCT) and Creative Destruction Lab.
Jonathan enjoys backcountry camping and hiking and serves as a director of a non-profit organization that provides outdoor educational programming to inner-city children to help foster self-confidence, resilience, and a deep connection with nature.
Jonathan Yeh active positions
| Companies | Position | Start |
|---|---|---|
Saisei Ventures LLC
 Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Founder | 01/11/2020 |
Ryne Biotechnology, Inc.
 Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Founder | 01/03/2022 |
Former positions of Jonathan Yeh
| Companies | Position | End |
|---|---|---|
| HEALIOS K.K. | Private Equity Investor | 31/01/2021 |
Centre For Commercialization of Regenerative Medicine
 Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Director/Board Member | 30/04/2020 |
Insitut de Recherche en Immunologie et en Cancérologie
 Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Consultant / Advisor | 30/04/2017 |
Genome Canada
 Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Director/Board Member | 30/04/2017 |
Training of Jonathan Yeh
| McGill University | Doctorate Degree |
| John Molson School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| HEALIOS K.K. | Health Technology |
| Private companies | 5 |
|---|---|
Genome Canada
Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Commercial Services |
Centre For Commercialization of Regenerative Medicine
Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Health Technology |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Commercial Services |
Saisei Ventures LLC
Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Ryne Biotechnology, Inc.
Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Health Technology |
- Stock Market
- Insiders
- Jonathan Yeh
